MKI67 and neoplasm: PCNA and Ki-67 staining were lower in the CTX-INS-GNP-treated group than in the other two groups, indicating that the addition of the nanoparticles to standard of care therapy reduced tumor proliferation and tissue repair levels (Figure 4 and Figure S3).